538
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

The Effect of Optive and Optive Advanced Artificial Tears on the Healthy Tear Film

ORCID Icon, , , &
Pages 588-594 | Received 03 Oct 2017, Accepted 16 Jan 2018, Published online: 01 Feb 2018

References

  • Evangelista M, Koverech A, Messano M, Pescosolido N. Comparison of three lubricant eye drop solutions in dry eye patients. Optom Vis Sci 2011; 88; 1439–44.
  • Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res 2004; 78; 347–60.
  • Sakimoto T, Shoji J, Yamada A, Sawa M. Upregulation of matrix metalloproteinases in tear fluid of patients with recurrent corneal erosion. Jap J Ophthalmol 2007; 51; 343–46.
  • Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol 2002; 133; 181–86.
  • Dursun D, Monroy D, Knighton R, Tervo T, Vesaluoma M, Carraway K, Feuer W, Pflugfelder SC. The effects of experimental tear film removal on corneal surface regularity and barrier function. Ophthalmology 2000; 107; 1754–60.
  • Gipson IK. Distribution of mucins at the ocular surface. Exp Eye Res 2004; 78; 379–88.
  • The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 2007; 5: 75–92.
  • Lemp MA, Bron AJ, Baudouin C. Benitez Del Castillo JM, Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011; 151; 792–98.
  • Baudouin C, Aragona P, Messmer EM, Tomlinson A, Calonge M, Boboridis KG, Akova YA, Geerling G, Labetoulle M, Rolando M Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf 2013; 11: 246–58.
  • Kaercher T, Thelen U, Brief G, Morgan-Warren RJ, Leaback R. A prospective, multicenter, noninterventional study of Optive Plus® in the treatment of patients with dry eye: the prolipid study. Clinical Ophthalmology. 2014; 8: 1147–55. doi: 10.2147/OPTH.
  • Lemp MA. Management of dry eye disease. Am J Manag Care 2008; 14; S88–101.
  • Simmons PA, Carlisle-Wilcox C, Chen R, Liu H, Vehige JG. Efficacy, safety, and acceptability of a lipid-based artificial tear formulation: a randomized, controlled, multicenter clinical trial. Clinical Therapeutics. 2015; 37: 858–68. doi: 10.1016/j.clinthera.2015.01.001.
  • Korb DR, Scaffidi RC, Greiner JV, Kenyon KR, Herman JP, Blackie CA, Glonek T, Case CL, Finnemore VM, Douglass T. The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms. Optom Vis Sci 2005; 82; 594–601.
  • Wojtowicz JC, Arciniega JC, McCulley JP, Mootha VV. Effect of systane and optive on aqueous tear evaporation in patients with dry eye disease. Eye Contact Lens 2010; 36; 358–60.
  • Lee SY, Tong L. Lipid-containing lubricants for dry eye: a systematic review. Optom Vis Sci 2012; 89; 1654–61.
  • Maissa C, Guillon M, Simmons P, Vehige J. Effect of castor oil emulsion eyedrops on tear film composition and stability. Cont Lens Anterior Eye 2010; 33; 76–82.
  • Messmer EM. Osmoprotection as a new therapeutic principle. Ophthalmologe 2007; 104; 987–90.
  • Pearce EI, Tomlinson A, Blades KJ, Falkenberg HK, Lindsay B, Wilson CG. Effect of an oil and water emulsion on tear evaporation rate. Adv Exp Med Biol 2002; 506; 419–23.
  • Fuller DG, Potts K, Kim J. Noninvasive tear breakup times and ocular surface disease. Optom Vis Sci 2013; 90; 1086–91.
  • Van Santvliet L, Ludwig A. Determinants of eye drop size. Surv Ophthalmol 2004; 49; 197–213.
  • Madden LC, Tomlinson A, Simmons PA. Effect of humidity variations in a controlled environment chamber on tear evaporation after dry eye therapy. Eye Contact Lens 2013; 39; 169–74.
  • Abusharha AA, Pearce EI, Fagehi R. Effect of ambient temperature on the human tear film. Eye Contact Lens 2016; 42; 308–12.
  • Finis D, Pischel N, Schrader S, Geerling G. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction. Cornea 2013; 32; 1549–53.
  • Olson MC, Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction. Eye Contact Lens 2003; 29; 96–99.
  • Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000; 118; 615–21.
  • Ehrmann K, Fedtke C, Radic A. Assessment of computer generated vision charts. Cont Lens Anterior Eye 2009; 32; 133–40.
  • Cornea and Contact Lens Research Unit. C.C.L.R.U. Grading Scales. 1996. University of New South Wales, Sydney, Australia.
  • Zhao Y, Tan CL, Tong L. Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness. BMC Ophthalmol 2015; 15; 53.
  • Holm S. A Simple Sequentially Rejective Multiple Test Procedure. Scand J Stat 1979; 6; 65–70.
  • Bartlett JD, Keith MS, Sudharshan L, Snedecor SJ. Associations between signs and symptoms of dry eye disease: a systematic review. Clin Ophthalmol 2015; 9; 1719–30.
  • Goto E, Shimazaki J, Monden Y, Takano Y, Yagi Y, Shimmura S, Tsubota K. Low-concentration homogenized castor oil eye drops for noninflamed obstructive meibomian gland dysfunction. Ophthalmology 2002; 109; 2030–35.
  • Khanal S, Tomlinson A, Pearce EI, Simmons PA. Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye. Cornea 2007; 26; 175–81.
  • Di Pascuale MA, Goto E, Tseng SC. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients. Ophthalmology 2004; 111; 783–91.
  • Jung JW, Park SY, Kim JS, Kim EK, Seo KY, Kim TI. Analysis of factors associated with the tear film lipid layer thickness in normal eyes and patients with dry eye syndrome. Invest Ophthalmol Vis Sci 2016; 57; 4076–83.
  • Calvao-Santos G, Borges C, Nunes S, Salgado-Borges J, Duarte L. Efficacy of 3 different artificial tears for the treatment of dry eye in frequent computer users and/or contact lens users. Eur J Ophthalmol 2011; 21; 538–44.
  • Lanzini M, Curcio C, Colabelli-Gisoldi RA, Mastropasqua A, Calienno R, Agnifili L, Nubile M, Mastropasqua L. In vivo and impression cytology study on the effect of compatible solutes eye drops on the ocular surface epithelial cell quality in dry eye patients. Mediators Inflamm 2015; 2015; 351424.
  • Guillon M, Maissa C, Ho S. Evaluation of the effects on conjunctival tissues of Optive eyedrops over one month usage. Cont Lens Anterior Eye 2010; 33; 93–99.
  • Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern M, Pflugfelder SC. Experimentally induced dry eye produces ocular surface inflammation and epithelial disease. Adv Exp Med Biol 2002; 506; 647–55.
  • Li DQ, Chen Z, Song XJ, Luo L, Pflugfelder SC. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2004; 45; 4302–11.
  • Daull P, Feraille L, Elena PP, Garrigue JS. Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping. J Ocul Pharmacol Ther 2016; 32; 109–18.
  • Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci 1997; 74; 8–13.
  • Scaffidi RC, Korb DR. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness. Eye Contact Lens 2007; 33; 38–44.
  • Kaercher T, Buchholz P, Kimmich F. Treatment of patients with keratoconjunctivitis sicca with Optive: results of a multicenter, open-label observational study in Germany. Clin Ophthalmol 2009; 3; 33–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.